THERAPEUTIC CLASS

ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation

---

In view of available evidence, genetic testing of ACE I/D polymorphism prior to clinical
decision making is not currently justified. The relation between ACE genetic variation and response
to treatment in CAD remains an unresolved issue. The results of long-term and properly designed
prospective studies hold the promise for pharmacogenetically tailored therapy in CAD.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Cardiovascular & Hematopoietic System

Specific Detail Info

BMC Medical Genetics 2009, 10:50

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment